Back to search

Article

Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells

2021-09-29

Abstract excerpt

Current immunotherapeutics often work by directing components of the immune system to recognize biomarkers on the surface of cancer cells to generate an immune response. However, variable changes in biomarker distribution and expression can result in uneven patient response. The development of a more universal tumor-homing strategy has the potential to improve selectivity and extend therapy to cancers with decreas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d765dba-7d1d-5f7a-bdc5-ecc64ac0a10c
DOI
10.1101/2021.09.27.462035
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune CellsDOI 10.1101/2021.09.27.462035
Select a neighboring publication to make it the new centre.